1. Pyrogallol-Phloroglucinol-6,6-Bieckol Alleviates Obesity and Systemic Inflammation in a Mouse Model by Reducing Expression of RAGE and RAGE Ligands
   Junwon Choi et al, 2019, Marine Drugs CrossRef
2. Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)
   Zhou Haiyan et al, 2020, BioMed Research International CrossRef
3. Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
   Zheng Xiao et al, 2020, Front. Cardiovasc. Med. CrossRef
4. Angiotensin II Increases HMGB1 Expression in the Myocardium Through AT1 and AT2 Receptors When Under Pressure Overload.
   Lei Zhang et al, 2021, Int Heart J CrossRef
5. Translating the force—mechano-sensing GPCRs
   Caroline Wilde et al, 2022, American Journal of Physiology-Cell Physiology CrossRef
6. Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway
   Ruihua Fan et al, 2022, Front. Mol. Neurosci. CrossRef
7. Toll-like receptors in cardiac hypertrophy
   Yanan Zhang et al, 2023, Front. Cardiovasc. Med. CrossRef
8. High-Mobility Group Box-1 Is Associated With Obesity, Inflammation, and Subclinical Cardiovascular Risk Among Young Adults: A Longitudinal Cohort Study.
   Li Chen et al, 2020, Arterioscler Thromb Vasc Biol CrossRef
9. Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
   Zhuyubing Fang et al, 2024, ESC Heart Failure CrossRef